Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00453544 · ClinicalTrials.gov registry record · NA
Enhancing Consent for Alzheimer's Research
A NA study, sponsored by University of California, San Diego.
- Completed
- Registry status
- NA
- Development phase
- 252
- Enrollment target
NCT00453544 is a NA study that has completed, run by University of California, San Diego. The registered enrollment target is 252 participants.
The verdict
NCT00453544, a NA study, has completed, sponsored by University of California, San Diego.
- COMPLETED
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of an enhanced consent procedure for patients with mild-to-moderate Alzheimer disease, and to identify factors and patient characteristics that predict the degree to which enhanced consent is more beneficial than routine consent procedures.
Interventions
- OTHER Enhanced Consent Procedure
- OTHER Routine Consent Procedure
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2006-04 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00453544
The ClinicalTrials.gov registry entry for NCT00453544 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 252 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Diego, which has 775 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Enhanced Consent Procedure is the first listed.
NCT00453544 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00453544 about?
NCT00453544 is a clinical study titled "Enhancing Consent for Alzheimer's Research". The purpose of this study is to evaluate the efficacy of an enhanced consent procedure for patients with mild-to-moderate Alzheimer disease, and to identify factors and patient characteristics that predict the degree to which enhanced consent is more beneficial than routine consent procedures.
What is the current status of trial NCT00453544?
This trial is currently completed. It is a NA study. The enrollment target is 252 participants. The study started on 2006-04. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00453544?
The interventions under investigation include: Enhanced Consent Procedure (OTHER), Routine Consent Procedure (OTHER).
Who is sponsoring clinical trial NCT00453544?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.